Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA issues complete response letter for FluMist BLA

Sep. 5, 2001

Immunomodulatory peptides identified by Entopharm

Sep. 4, 2001

Avax granted licensing option for SCID gene therapy technology

Aug. 29, 2001

Novel cytokine production inhibitors highlighted at the ongoing ACS meeting

Aug. 28, 2001

New series of inhibitors of TNF production may be useful as immunosuppressants

Aug. 27, 2001

Intermune completes enrollment in phase III trial of Actimmune for treatment of IPF

Aug. 24, 2001

Malaria vaccine MuStDO-5 found safe in preclinical studies

Aug. 24, 2001

Novel glycoalkaloid tomatine has potential as adjuvant in malaria vaccine development

Aug. 23, 2001

Rituximab tested as a treatment for chronic ITP

Aug. 14, 2001

Product R enhances production and secretion of proinflammatory chemokines in human monocytes

Aug. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...